BFNH OTC
BioForce Nanosciences Holdings, Inc.
1W: -22.7%
1M: +44.6%
3M: +257.9%
YTD: +1146.5%
1Y: +791.2%
3Y: +435.6%
5Y: +1012.3%
$7.55
-1.17 (-13.42%)
Weekly Expected Move ±23.0%
$4
$6
$7
$9
$11
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$490K
-3.9% ▼
Net Income
-$490K
-3.9% ▼
EPS (Diluted)
$-0.02
-4.3% ▼
EBITDA
-$490K
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $158M | $502K | $486K | $472K | $67K |
| Operating Expenses | $158M | $502K | $486K | $472K | $490K |
| Operating Income | -$158M | -$502K | -$486K | -$472K | -$490K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$158M | -$502K | -$486K | -$472K | -$490K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$158M | -$502K | -$486K | -$472K | -$490K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-9.72 | $-0.02 | $-0.02 | $-0.02 | $-0.02 |
| EBITDA | -$158M | -$502K | -$486K | $0 | -$490K |
| Shares Outstanding | 16M | 29M | 29M | 29M | 29M |